ICLR
VENTE TOTALE: 8 179 titres (~1 331 299,44 $ US)
- Insiders
- Whitaker Anne Clem, O''Neill Julie, Murray Ciaran, Murphy Ronan Martin, McCague Eugene Pacelli, Grais Linda, CLIMAX JOHN DR, Balfe Barry Edward
- Total bought
- —
- Total sold
- $1,331,299
- Last activity
- 2026-08-11
- Last synced
-
2026-08-21 23:36:53
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Bearish signal Scored 2026-08-11
ICLR presents a deteriorating financial profile with severe margin compression (net margin collapsing from 9.56% to 2.78%) and a near-critical debt service coverage ratio of 1.12, leaving virtually no operational buffer.
The first sentence of the analysis written for ICLR on 2026-08-11 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 26.4% | 29.4% | 29.6% | 28.6% | 27.5% | |
| Ebit Margin | 5.3% | 13.0% | 11.5% | 10.3% | 6.9% | |
| Ebitda Margin | 10.0% | 18.9% | 18.7% | 18.2% | 13.5% | |
| Operating Profit Margin | 12.3% | 13.3% | 11.8% | 10.3% | 6.9% | |
| Pretax Profit Margin | 3.1% | 10.5% | 7.7% | 7.3% | 3.5% | |
| Continuous Operations Profit Margin | 2.8% | 9.6% | 7.5% | 6.5% | 2.8% | |
| Net Profit Margin | 2.8% | 9.6% | 7.5% | 6.5% | 2.8% | |
| Bottom Line Profit Margin | 2.8% | 9.6% | 7.5% | 6.5% | 2.8% | |
| Current Ratio | 1.096 | 1.263 | 1.207 | 1.200 | 1.186 | |
| Quick Ratio | 1.096 | 1.263 | 1.207 | 1.198 | 1.186 | |
| Solvency Ratio | 0.087 | 0.174 | 0.155 | 0.129 | 0.055 | |
| Cash Ratio | 0.203 | 0.193 | 0.134 | 0.107 | 0.303 | |
| Price To Earnings Ratio | 62.404 | 21.845 | 37.945 | 31.331 | 135.833 | |
| Price To Earnings Growth Ratio | -0.897 | 0.762 | 1.867 | 0.182 | -2.131 | |
| Forward Price To Earnings Growth Ratio | -0.897 | 0.762 | 1.867 | 0.182 | -2.131 | |
| Price To Earnings Diluted Ratio | 62.834 | 22.005 | 38.253 | 31.688 | 137.644 | |
| Price To Earnings Diluted Growth Ratio | -0.903 | 0.765 | 1.846 | 0.184 | -2.153 | |
| Price To Book Ratio | 1.554 | 1.816 | 2.515 | 1.864 | 2.576 | |
| Price To Sales Ratio | 1.732 | 2.089 | 2.862 | 2.046 | 3.792 | |
| Price To Free Cash Flow Ratio | 16.578 | 15.464 | 22.777 | 37.605 | 28.263 | |
| Price To Operating Cash Flow Ratio | 13.791 | 13.444 | 20.017 | 28.115 | 25.067 | |
| Debt To Assets Ratio | 0.219 | 0.213 | 0.232 | 0.281 | 0.325 | |
| Debt To Equity Ratio | 0.387 | 0.378 | 0.426 | 0.568 | 0.700 | |
| Debt To Capital Ratio | 0.279 | 0.274 | 0.299 | 0.362 | 0.412 | |
| Long Term Debt To Capital Ratio | 0.238 | 0.263 | 0.284 | 0.351 | 0.400 | |
| Financial Leverage Ratio | 1.770 | 1.772 | 1.839 | 2.022 | 2.155 | |
| Working Capital Turnover Ratio | 15.874 | 12.548 | 14.445 | 15.472 | 7.605 | |
| Operating Cash Flow Ratio | 0.324 | 0.460 | 0.411 | 0.209 | 0.334 | |
| Operating Cash Flow Sales Ratio | 0.126 | 0.155 | 0.143 | 0.073 | 0.151 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.832 | 0.869 | 0.879 | 0.748 | 0.887 | |
| Debt Service Coverage Ratio | 1.115 | 5.566 | 3.379 | 4.749 | 2.938 | |
| Interest Coverage Ratio | 5.382 | 4.627 | 2.840 | 3.462 | 2.075 | |
| Short Term Operating Cash Flow Coverage Ratio | 1.956 | 43.231 | 10.540 | 10.214 | 15.034 | |
| Operating Cash Flow Coverage Ratio | 0.291 | 0.357 | 0.295 | 0.117 | 0.147 | |
| Capital Expenditure Coverage Ratio | 5.948 | 7.656 | 8.252 | 3.963 | 8.844 | |
| Dividend Paid And Capex Coverage Ratio | 5.948 | 7.656 | 8.252 | 3.963 | 8.844 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 20.883 | 13.020 | 17.615 | 14.429 | 34.726 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 26.4% | ▼-3.0% | ▼-1.9% |
| Ebit Margin | 5.3% | ▼-7.6% | ▼-4.1% |
| Ebitda Margin | 10.0% | ▼-8.9% | ▼-5.9% |
| Operating Profit Margin | 12.3% | ▼-1.0% | ▲1.4% |
| Pretax Profit Margin | 3.1% | ▼-7.4% | ▼-3.4% |
| Continuous Operations Profit Margin | 2.8% | ▼-6.8% | ▼-3.1% |
| Net Profit Margin | 2.8% | ▼-6.8% | ▼-3.1% |
| Bottom Line Profit Margin | 2.8% | ▼-6.8% | ▼-3.1% |
| Current Ratio | 1.096 | ▼-0.167 | ▼-0.095 |
| Quick Ratio | 1.096 | ▼-0.167 | ▼-0.094 |
| Solvency Ratio | 0.086 | ▼-0.087 | ▼-0.033 |
| Cash Ratio | 0.203 | ▲0.010 | ▲0.015 |
| Price To Earnings Ratio | 62.404 | ▲40.559 | ▲4.532 |
| Price To Earnings Growth Ratio | -0.897 | ▼-1.658 | ▼-0.854 |
| Forward Price To Earnings Growth Ratio | -0.897 | ▼-1.658 | ▼-0.854 |
| Price To Earnings Diluted Ratio | 62.834 | ▲40.829 | ▲4.349 |
| Price To Earnings Diluted Growth Ratio | -0.903 | ▼-1.668 | ▼-0.851 |
| Price To Book Ratio | 1.554 | ▼-0.262 | ▼-0.511 |
| Price To Sales Ratio | 1.732 | ▼-0.357 | ▼-0.772 |
| Price To Free Cash Flow Ratio | 16.578 | ▲1.115 | ▼-7.559 |
| Price To Operating Cash Flow Ratio | 13.791 | ▲0.347 | ▼-6.296 |
| Debt To Assets Ratio | 0.219 | ▲0.005 | ▼-0.035 |
| Debt To Equity Ratio | 0.387 | ▲0.008 | ▼-0.105 |
| Debt To Capital Ratio | 0.279 | ▲0.004 | ▼-0.046 |
| Long Term Debt To Capital Ratio | 0.238 | ▼-0.025 | ▼-0.069 |
| Financial Leverage Ratio | 1.770 | ▼-0.003 | ▼-0.142 |
| Working Capital Turnover Ratio | 15.874 | ▲3.326 | ▲2.685 |
| Operating Cash Flow Ratio | 0.324 | ▼-0.136 | ▼-0.024 |
| Operating Cash Flow Sales Ratio | 0.126 | ▼-0.030 | ▼-0.004 |
| Free Cash Flow Operating Cash Flow Ratio | 0.832 | ▼-0.037 | ▼-0.011 |
| Debt Service Coverage Ratio | 1.115 | ▼-4.451 | ▼-2.434 |
| Interest Coverage Ratio | 5.382 | ▲0.755 | ▲1.705 |
| Short Term Operating Cash Flow Coverage Ratio | 1.956 | ▼-41.275 | ▼-14.239 |
| Operating Cash Flow Coverage Ratio | 0.291 | ▼-0.066 | ▲0.050 |
| Capital Expenditure Coverage Ratio | 5.948 | ▼-1.708 | ▼-0.985 |
| Dividend Paid And Capex Coverage Ratio | 5.948 | ▼-1.708 | ▼-0.985 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 20.883 | ▲7.863 | ▲0.749 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $14.29B | $17.30B | $23.24B | $15.84B | $20.78B | |
| Enterprise value | $17.20B | $20.36B | $26.80B | $20.38B | $25.68B | |
| EV / Sales | 2.08x | 2.46x | 3.30x | 2.63x | 4.68x | |
| EV / Op. cash flow | 16.60x | 15.82x | 23.08x | 36.18x | 30.97x | |
| EV / Free cash flow | 19.95x | 18.20x | 26.27x | 48.39x | 34.92x | |
| EV / EBITDA | 20.88x | 13.02x | 17.61x | 14.43x | 34.73x | |
| Net debt / EBITDA | 3.53x | 1.96x | 2.34x | 3.21x | 6.62x | |
| Current ratio | 1.10x | 1.26x | 1.21x | 1.20x | 1.19x | |
| Income quality | 4.52x | 1.63x | 1.90x | 1.11x | 5.41x | |
| Graham number | $88 | $158 | $137 | $121 | $79 | |
| Graham net-net | -$56 | -$57 | -$63 | -$77 | -$104 | |
| Tax burden | 90.8% | 91.1% | 98.1% | 89.5% | 78.8% | |
| Interest burden | 57.3% | 80.8% | 66.7% | 70.8% | 51.3% | |
| Working capital | $305.5M | $734.1M | $585.9M | $538.5M | $462.3M | |
| Invested capital | $12.81B | $13.88B | $13.97B | $14.29B | $14.75B | |
| Return on assets | 1.4% | 4.7% | 3.6% | 2.9% | 0.9% | |
| Operating ROA | 6.1% | 6.5% | 5.6% | 4.6% | 3.6% | |
| Return on tangible assets | 5.3% | 18.6% | 14.9% | 12.8% | 4.2% | |
| Return on equity | 2.5% | 8.3% | 6.6% | 5.9% | 1.9% | |
| Return on invested capital | 6.7% | 7.1% | 6.6% | 4.9% | 2.0% | |
| Return on capital employed | 7.7% | 7.8% | 6.8% | 5.5% | 2.5% | |
| Earnings yield | 1.6% | 4.6% | 2.6% | 3.2% | 0.7% | |
| Free cash flow yield | 6.0% | 6.5% | 4.4% | 2.7% | 3.5% | |
| Capex / Op. cash flow | 16.8% | 13.1% | 12.1% | 25.2% | 11.3% | |
| Capex / Depreciation | 45.5% | 31.8% | 24.0% | 25.0% | 29.8% | |
| Capex / Sales | 2.1% | 2.0% | 1.7% | 1.8% | 1.7% | |
| SG&A / Sales | 9.5% | 8.8% | 9.6% | 10.1% | 10.7% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.2% | 0.6% | 0.7% | 0.9% | 2.4% | |
| Intangibles / Total assets | 73.6% | 74.7% | 75.8% | 77.1% | 79.1% | |
| Days sales outstanding | 122d | 126d | 130d | 132d | 138d | |
| Days payables outstanding | 47d | 44d | 38d | 40d | 21d | |
| Operating cycle | 122d | 126d | 130d | 133d | 138d | |
| Cash conversion cycle | 75d | 82d | 92d | 92d | 117d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-17.4%EV / Sales ▼-15.2%EV / EBITDA ▲+60.4%EV / Op. cash flow ▲+0.773Earnings yield ▼-0.030Graham number ▼-70.056
Profitability
Return on equity ▼-0.058Return on assets ▼-0.033Return on invested capital ▼-0.003Return on capital employed ▼-0.001Operating ROA ▼-0.004Income quality ▲+2.893Tax burden ▼-0.002
Efficiency
Days sales outstanding ▼-4.059Days payables outstanding ▲+2.913Operating cycle ▼-4.059Cash conversion cycle ▼-6.972Capex / Sales ▲+0.001R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.167Net debt / EBITDA ▲+1.572Working capital ▼-428587000.000Invested capital ▼-1066791000.000Intangibles / Total assets ▼-0.011
Change over 5 years
Valuation
Market cap ▼-31.2%EV / Sales ▼-55.5%EV / EBITDA ▼-39.9%EV / Op. cash flow ▼-14.371Earnings yield ▲+0.009Graham number ▲+9.255
Profitability
Return on equity ▲+0.006Return on assets ▲+0.005Return on invested capital ▲+0.048Return on capital employed ▲+0.052Operating ROA ▲+0.025Income quality ▼-0.894Tax burden ▲+0.121
Efficiency
Days sales outstanding ▼-16.444Days payables outstanding ▲+26.055Operating cycle ▼-16.444Cash conversion cycle ▼-42.499Capex / Sales ▲+0.004R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.091Net debt / EBITDA ▼-3.086Working capital ▼-156761000.000Invested capital ▼-1936623000.000Intangibles / Total assets ▼-0.054
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-03-05 | Kevin Hern | Sale | $100,001 - $250,000 |
| 2026-02-12 | Julia Letlow | Sale | $1,001 - $15,000 |
| 2024-09-04 | John James | Sale (Full) | $1,001 - $15,000 |
| 2024-06-12 | John James | Purchase | $1,001 - $15,000 |
| 2023-01-31 | Kevin Hern | Sale (Full) | $1,001 - $15,000 |
| 2021-05-18 | Kevin Hern | Purchase | $100,001 - $250,000 |
| 2020-07-27 | Kevin Hern | Purchase | $1,001 - $15,000 |
Recent news
- 2026-08-11 Oakmark Concentrated Strategy Q2 2026 Performance Review The portfolio''s return was 9.21% (net) for the reporting period. Centene, ICON and Keurig Dr Pepper were the contributors during the quarter. Intercontinental Exchange, Salesforce and ConocoPhillips were the detractors during the quarter.
- 2026-08-06 Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist? ICLR''s discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.
- 2026-08-06 ICON Announces Pricing of USD 2.15 Billion Notes DUBLIN--(BUSINESS WIRE)--ICON Announces Pricing of USD 2.15 Billion Notes.
- 2026-08-05 ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen ICON''s 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.
- 2026-08-04 ICON Announces Private Offering of Notes DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading clinical research organization, announced today that its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the “Issuer”), intends to offer one or more series of senior notes (the “Notes”), in a private offering (the “Offering”) with registration rights, subject to market and other conditions. The Notes will be guaranteed on a senior unsecured basis by ICON.
- 2026-08-01 Icon Plc $ICLR Shares Sold by Avidity Partners Management LP Avidity Partners Management LP lowered its stake in Icon Plc (NASDAQ: ICLR) by 51.7% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 16,000 shares of the medical research company''s stock after selling 17,100 shares during the period. Icon makes up about 0.4%
- 2026-07-31 ICON Announces Results of Annual General Meeting DUBLIN--(BUSINESS WIRE)--ICON Announces Results of Annual General Meeting.
- 2026-07-30 ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript
- 2026-07-30 Icon Q2 Earnings Call Highlights Icon NASDAQ: ICLR reported second-quarter 2026 revenue growth and strong bookings as higher pass-through activity supported the top line, while the company continued to manage business-mix pressures affecting reported margins.
- 2026-07-29 Icon PLC (ICLR) Lags Q2 Earnings Estimates Icon PLC (ICLR) came out with quarterly earnings of $2.56 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $3.26 per share a year ago.